新型冠状病毒肺炎合并缺血性脑卒中患者的治疗与康复特点
[Features of treatment and rehabilitation of COVID-19 patients with ischemic stroke].
作者信息
Rakhimbayeva G S, Gazieva Sh R, Ataniyazov M K, Muratov F H, Tolipov D S, Shodiev U D
机构信息
Tashkent Medical Academy, Tashkent, Republic of Uzbekistan.
出版信息
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(3. Vyp. 2):76-84. doi: 10.17116/jnevro202312303276.
The development of COVID-19 is associated with damage to various organs and organ systems, including the development of acute ischemic stroke (AI). The article examines modern ideas about the pathogenesis of AI in COVID-19. The data on the choice of optimal therapy for patients with acute AI and COVID-19, as well as on the possibility of improving the effectiveness of rehabilitation measures, are analyzed. Information is provided on the efficacy of the drug Mexidol in patients with AI and COVID-19.
新型冠状病毒肺炎（COVID-19）的发展与包括急性缺血性中风（AI）在内的各种器官和器官系统的损伤有关。本文探讨了关于COVID-19中AI发病机制的现代观点。分析了急性AI和COVID-19患者最佳治疗选择的数据，以及提高康复措施有效性的可能性。提供了美西多宁药物对AI和COVID-19患者疗效的信息。
Zotero 插件